• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

急性心肌梗死溶栓治疗后,TIMI心肌灌注分级、血流分级、帧数及经皮冠状动脉介入治疗与长期预后的关系。

Relationship of the TIMI myocardial perfusion grades, flow grades, frame count, and percutaneous coronary intervention to long-term outcomes after thrombolytic administration in acute myocardial infarction.

作者信息

Gibson C Michael, Cannon Christopher P, Murphy Sabina A, Marble Susan J, Barron Hal V, Braunwald Eugene

机构信息

TIMI Study Group, Department of Medicine, Brigham and Women's Hospital, Boston, Mass 02215, USA.

出版信息

Circulation. 2002 Apr 23;105(16):1909-13. doi: 10.1161/01.cir.0000014683.52177.b5.

DOI:10.1161/01.cir.0000014683.52177.b5
PMID:11997276
Abstract

BACKGROUND

Although 90-minute TIMI flow grades (TFGs), corrected TIMI frame counts (CTFCs), and TIMI myocardial perfusion grades (TMPGs) have been associated with 30-day outcomes, we hypothesized that these indices would be related to long-term outcomes after thrombolytic administration.

METHODS AND RESULTS

As a substudy of the TIMI 10B trial (tissue plasminogen activator versus tenecteplase), 49 centers carried out 2-year follow-up. TIMI grade 2/3 flow (Cox hazard ratio [HR] 0.41, P=0.001), reduced CTFCs (faster flow, P=0.02), and an open microvasculature (TMPG 2/3) (HR 0.51, P=0.038) were all associated with improved 2-year survival. Rescue percutaneous coronary intervention (PCI) of closed arteries (TFG 0/1) at 90 minutes was associated with reduced mortality (P=0.03), and mortality trended lower with adjunctive PCI of open (TFG 2/3) arteries (P=0.11). In a multivariate model correcting for previously identified correlates of mortality (age, sex, pulse, left anterior descending coronary artery infarction, and any PCI during initial hospitalization), patency (TFG 2/3) (HR 0.32, P<0.001), CTFC (P=0.01), and TMPG 2/3 remained associated with reduced mortality (HR 0.46, P=0.02).

CONCLUSIONS

Both improved epicardial flow (TFG 2/3 and low CTFCs) and tissue-level perfusion (TMPG 2/3) at 90 minutes after thrombolytic administration are independently associated with improved 2-year survival, suggesting complementary mechanisms of improved long-term survival. Although rescue PCI reduced long-term mortality, improved microvascular perfusion (TMPG 2/3) before PCI was also related to improved mortality independently of epicardial blood flow and the performance of rescue or adjunctive PCI. Further prospective trials are warranted to re-examine the benefit of early PCI with thrombolysis.

摘要

背景

尽管90分钟的心肌梗死溶栓治疗(TIMI)血流分级(TFG)、校正的TIMI帧计数(CTFC)和TIMI心肌灌注分级(TMPG)与30天预后相关,但我们推测这些指标与溶栓治疗后的长期预后有关。

方法与结果

作为TIMI 10B试验(组织型纤溶酶原激活剂与替奈普酶对比)的一项子研究,49个中心进行了为期2年的随访。TIMI 2/3级血流(Cox风险比[HR] 0.41,P = 0.001)、较低的CTFC(血流更快,P = 0.02)以及开放的微血管(TMPG 2/3)(HR 0.51,P = 0.038)均与2年生存率提高相关。90分钟时对闭塞动脉(TFG 0/1)进行补救性经皮冠状动脉介入治疗(PCI)与死亡率降低相关(P = 0.03),对开放动脉(TFG 2/3)进行辅助性PCI时死亡率有降低趋势(P = 0.11)。在一个校正了先前确定的死亡率相关因素(年龄、性别、脉搏、左前降支冠状动脉梗死以及初次住院期间的任何PCI)的多变量模型中,血管通畅(TFG 2/3)(HR 0.32,P < 0.001)、CTFC(P = 0.01)和TMPG 2/3仍与死亡率降低相关(HR 0.46,P = 0.02)。

结论

溶栓治疗后90分钟时改善的心外膜血流(TFG 2/3和低CTFC)和组织水平灌注(TMPG 2/3)均与2年生存率提高独立相关,提示改善长期生存的互补机制。尽管补救性PCI降低了长期死亡率,但PCI前改善的微血管灌注(TMPG 2/3)也与死亡率改善相关,且独立于心外膜血流以及补救性或辅助性PCI的实施情况。有必要进行进一步的前瞻性试验以重新审视早期PCI联合溶栓治疗的益处。

相似文献

1
Relationship of the TIMI myocardial perfusion grades, flow grades, frame count, and percutaneous coronary intervention to long-term outcomes after thrombolytic administration in acute myocardial infarction.急性心肌梗死溶栓治疗后,TIMI心肌灌注分级、血流分级、帧数及经皮冠状动脉介入治疗与长期预后的关系。
Circulation. 2002 Apr 23;105(16):1909-13. doi: 10.1161/01.cir.0000014683.52177.b5.
2
Relationship between TIMI frame count and clinical outcomes after thrombolytic administration. Thrombolysis In Myocardial Infarction (TIMI) Study Group.溶栓治疗后心肌梗死溶栓试验(TIMI)帧数与临床结局的关系。心肌梗死溶栓试验(TIMI)研究组。
Circulation. 1999 Apr 20;99(15):1945-50. doi: 10.1161/01.cir.99.15.1945.
3
Association of duration of symptoms at presentation with angiographic and clinical outcomes after fibrinolytic therapy in patients with ST-segment elevation myocardial infarction.ST段抬高型心肌梗死患者溶栓治疗后就诊时症状持续时间与血管造影及临床结局的相关性
J Am Coll Cardiol. 2004 Sep 1;44(5):980-7. doi: 10.1016/j.jacc.2004.05.059.
4
Impaired coronary blood flow in nonculprit arteries in the setting of acute myocardial infarction. The TIMI Study Group. Thrombolysis in myocardial infarction.急性心肌梗死时非罪犯动脉的冠状动脉血流受损。TIMI研究组。心肌梗死溶栓治疗。
J Am Coll Cardiol. 1999 Oct;34(4):974-82. doi: 10.1016/s0735-1097(99)00335-6.
5
Association of the timing of ST-segment resolution with TIMI myocardial perfusion grade in acute myocardial infarction.急性心肌梗死中ST段回落时间与TIMI心肌灌注分级的相关性
Am Heart J. 2004 May;147(5):847-52. doi: 10.1016/j.ahj.2003.11.015.
6
Plasma N-terminal fragment of the prohormone B-type natriuretic peptide concentrations in relation to time to treatment and Thrombolysis in Myocardial Infarction (TIMI) flow: a substudy of the Assessment of the Safety and Efficacy of a New Treatment Strategy with Percutaneous Coronary Intervention (ASSENT IV-PCI) trial.原代 B 型利钠肽前体 N 端片段浓度与治疗时间及心肌梗死溶栓治疗 (TIMI) 血流的关系:经皮冠状动脉介入治疗评估新治疗策略安全性和有效性的一项亚组研究 (ASSENT IV-PCI 试验)。
Am Heart J. 2010 Jan;159(1):131-40. doi: 10.1016/j.ahj.2009.11.001.
7
Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs.溶栓药物给药后TIMI心肌灌注分级与死亡率的关系。
Circulation. 2000 Jan 18;101(2):125-30. doi: 10.1161/01.cir.101.2.125.
8
Association of a negative residual stenosis following rescue/adjunctive percutaneous coronary intervention with impaired myocardial perfusion and adverse outcomes among ST-segment elevation myocardial infarction patients.ST段抬高型心肌梗死患者中,补救/辅助经皮冠状动脉介入治疗后残余狭窄阴性与心肌灌注受损及不良结局的关联。
J Am Coll Cardiol. 2005 Feb 1;45(3):357-62. doi: 10.1016/j.jacc.2004.10.047.
9
Angiographic perfusion score: an angiographic variable that integrates both epicardial and tissue level perfusion before and after facilitated percutaneous coronary intervention in acute myocardial infarction.血管造影灌注评分:一种血管造影变量,整合了急性心肌梗死患者在易化经皮冠状动脉介入治疗前后的心外膜和组织水平灌注情况。
Am Heart J. 2004 Aug;148(2):336-40. doi: 10.1016/j.ahj.2003.12.044.
10
Relation of hyperemic epicardial flow to outcomes among patients with ST-segment elevation myocardial infarction receiving fibrinolytic therapy.接受溶栓治疗的ST段抬高型心肌梗死患者充血性心外膜血流与预后的关系。
Am J Cardiol. 2008 May 1;101(9):1232-8. doi: 10.1016/j.amjcard.2007.12.023. Epub 2008 Mar 5.

引用本文的文献

1
Markers in Acute Coronary Syndrome: Distal Coronary Embolism at Percutaneous Coronary Intervention.急性冠状动脉综合征的标志物:经皮冠状动脉介入治疗时的冠状动脉远端栓塞
J Cardiovasc Dev Dis. 2025 Aug 19;12(8):315. doi: 10.3390/jcdd12080315.
2
TIMI Frame Count and Coronary Function in Women With Suspected Ischemia and Nonobstructed Coronary Arteries.疑似缺血且冠状动脉无阻塞的女性患者的心肌梗死溶栓治疗(TIMI)帧数与冠状动脉功能
JACC Adv. 2025 Mar;4(3):101611. doi: 10.1016/j.jacadv.2025.101611. Epub 2025 Feb 20.
3
Microcirculatory Resistance After Primary Percutaneous Coronary Intervention Predicts Residual Myocardial Damage and Scar Formation.
直接经皮冠状动脉介入治疗后的微循环阻力可预测残余心肌损伤和瘢痕形成。
J Am Heart Assoc. 2025 Feb 18;14(4):e036033. doi: 10.1161/JAHA.124.036033. Epub 2025 Feb 8.
4
Systemic and Cardiac Microvascular Dysfunction in Hypertension.高血压中的全身及心脏微血管功能障碍
Int J Mol Sci. 2024 Dec 11;25(24):13294. doi: 10.3390/ijms252413294.
5
TIMI frame count as a predictor of major adverse cardiovascular events during the first month after primary PCI.TIMI帧数作为直接经皮冠状动脉介入治疗后第一个月内主要不良心血管事件的预测指标。
Caspian J Intern Med. 2024 Sep 7;15(4):697-705. doi: 10.22088/cjim.15.4.697. eCollection 2024 Fall.
6
A Comparison of Dynamic SPECT Coronary Flow Reserve with TIMI Frame Count in the Treatment of Non-Obstructive Epicardial Coronary Patients.动态 SPECT 冠状动脉血流储备与 TIMI 帧数计数在非阻塞性心外膜冠状动脉患者治疗中的比较。
Clin Interv Aging. 2023 Nov 2;18:1831-1839. doi: 10.2147/CIA.S429450. eCollection 2023.
7
The Association Between Atherogenic Index of Plasma and No-Reflow Phenomenon in Acute Coronary Syndrome.血浆致动脉粥样硬化指数与急性冠状动脉综合征无复流现象的关系。
Anatol J Cardiol. 2023 Dec 1;27(12):712-719. doi: 10.14744/AnatolJCardiol.2023.3381. Epub 2023 Oct 9.
8
The SALINE Technique for the Treatment of the No-Reflow Phenomenon during Percutaneous Coronary Intervention in STEMI.用于治疗ST段抬高型心肌梗死患者经皮冠状动脉介入治疗期间无复流现象的生理盐水技术
J Clin Med. 2023 Mar 21;12(6):2405. doi: 10.3390/jcm12062405.
9
One-year results from the Assessing MICRO-vascular resistances IMR to predict outcome in ST-elevation myocardial infarction patients with multivessel disease undergoing primary PCI (AMICRO) trial.评估微血管阻力以预测多支血管病变的ST段抬高型心肌梗死患者接受直接经皮冠状动脉介入治疗(AMICRO)试验的一年结果。
Front Cardiovasc Med. 2022 Dec 2;9:1051174. doi: 10.3389/fcvm.2022.1051174. eCollection 2022.
10
Microcirculation function assessment in acute myocardial infarction: A systematic review of microcirculatory resistance indices.急性心肌梗死中的微循环功能评估:微循环阻力指数的系统评价
Front Cardiovasc Med. 2022 Nov 11;9:1041444. doi: 10.3389/fcvm.2022.1041444. eCollection 2022.